等待开盘 02-06 09:30:00 美东时间
-0.570
-6.18%
今日重点评级关注:HC Wainwright & Co.:上调Tempest Therapeutics评级至"买入",目标价11美元;Guggenheim:维持Sportradar Gr"买入"评级,目标价从34美元升至35美元
01-23 19:46
Inter (NASDAQ:INTR), the financial institution serving more than 41 million customers, has received regulatory approval from the Florida Office of Financial Regulation (OFR) and the Federal Reserve (FED) to establish a
01-17 04:52
今日重点评级关注:富国银行:维持Annexon"超配"评级,目标价从14美元升至27美元;瑞穗:上调Relmada Therapeutics评级至"跑赢大市",目标价从1美元升至10美元
2025-11-20 10:28
Itau BBA analyst Pedro Leduc downgrades Inter & Co (NASDAQ:INTR) from Outperform to Market Perform and lowers the price target from $11 to $10.
2025-11-19 18:35
Inter & Co shares are trading lower. The company reported Q3 financial resu...
2025-11-14 01:30
Inter & Co (NASDAQ:INTR) reported quarterly earnings of $0.14 per share which met the analyst consensus estimate. This is a 40 percent increase over earnings of $0.10 per share from the same period last year. The
2025-11-13 19:42
Companies Reporting Before The Bell • Edgewell Personal Care (NYSE:EPC) is proj...
2025-11-13 19:11
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从46美元升至47美元;富国银行:维持Kyverna Therapeutics"超配"评级,目标价从27美元升至31美元
2025-10-31 10:25
Goldman Sachs analyst Tito Labarta maintains Inter & Co (NASDAQ:INTR) with a Buy and raises the price target from $9 to $10.
2025-10-30 23:37
U.S. stock futures were lower this morning, with the Dow futures falling more t...
2025-10-17 21:05